Litigation Details for Mallinckrodt Hospital Products IP Limited v. Baxter Healthcare Corporation (D. Del. 2020)
✉ Email this page to a colleague
Mallinckrodt Hospital Products IP Limited v. Baxter Healthcare Corporation (D. Del. 2020)
| Docket | ⤷ Try a Trial | Date Filed | 2020-03-27 |
| Court | District Court, D. Delaware | Date Terminated | 2020-04-30 |
| Cause | 35:1 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | Plaintiff | Referred To | |
| Parties | MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED | ||
| Patents | 10,383,834; 6,992,218; 9,399,012; 9,610,265; 9,987,238 | ||
| Attorneys | Philip A. Rovner | ||
| Firms | Morris, Nichols, Arsht & Tunnell, LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Mallinckrodt Hospital Products IP Limited v. Baxter Healthcare Corporation
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for Mallinckrodt Hospital Products IP Limited v. Baxter Healthcare Corporation (D. Del. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-03-27 | 1 | Complaint | . 9,987,238 (“’238 patent”), and U.S. Patent No. 10,383,834 (“’834 patent”) and is the exclusive sub-licensee….S. Patent No. 9,399,012 (“’012 patent”), U.S. Patent No. 9,610,265 (“’265 patent”), U.S. Patent No. …sub-licensee of U.S. Patent No. 6,992,218 (“’218 patent”) (collectively, “Patents-in-Suit”). Case 1:… action for infringement of the Patents-in-Suit pursuant to the Patent Laws of the United States, 35 …involves patents that have already been at issue in prior actions before this Court. The ’218 patent was | External link to document |
| 2020-04-30 | 11 | Order | infringement of U.S. Patent Nos. 9,610,265, 9,399,012, 9,987,238, 6,992,21 8, and 10,383 ,834 (the "Plaintiffs…expiration of U.S. Patent No. 6,992,218 was a technical act of infringement of that patent under 35 U.S.C…PERMANENT INJUNCTION This action for patent infringement has been brought by Plaintiffs, Mallinckrodt…Plaintiffs Patents"). The Mallinckrodt Parties' commencement of this litigation was based …charged Baxter with infringement of the Plaintiffs Patents in connection with Baxter's submission of | External link to document |
| 2020-03-27 | 3 | Patent/Trademark Report to Commissioner of Patents | ;9,399,012 B2 ;9,610,265 B2 ;9,987,238 B2 ;10,383,834 B2. (lak) (Entered: 03/27/2020) 27 March 2020… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,992,218 B2 ;…2020 30 April 2020 1:20-cv-00434 835 Patent - Abbreviated New Drug Application(ANDA) Plaintiff | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
